Immage Biotherapeutics Corp.
Other OTCTotal Valuation
Immage Biotherapeutics Corp. carries a market capitalization of 15,174.00, placing it among publicly traded companies globally. Its enterprise value stands at -127,135.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 15,174.00 |
| Enterprise Value | -127,135.00 |
Share Statistics
Immage Biotherapeutics Corp. currently has 151.74M shares outstanding.
| Shares Outstanding | 151.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Immage Biotherapeutics Corp. maintains a current ratio of 1.30, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.30 |
| Quick Ratio | 1.24 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -621.10 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Immage Biotherapeutics Corp.'s stock has gained approximately 9900% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 9900% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -1.84M, while operating income came in at -1.85M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -1.85M |
| Pretax Income | -1.85M |
| Net Income | -1.85M |
| EBITDA | -1.84M |
| EBIT | -1.85M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Total book value stands at -1.82M, with working capital of 30,512.00 providing operational flexibility.
| Cash & Cash Equivalents | 127,135.00 |
| Total Debt | N/A |
| Net Debt | -127,135.00 |
| Equity (Book Value) | -1.82M |
| Book Value Per Share | -0.01 |
| Working Capital | 30,512.00 |
Cash Flow
Immage Biotherapeutics Corp. produced -261,342.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -261,342.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -261,342.00 |
| FCF Per Share | 0.00 |
Scores
Immage Biotherapeutics Corp. posts an Altman Z-Score of -54.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -54.22 |